Type I interferon exacerbates Mycobacterium tuberculosis induced human macrophage death.

TitleType I interferon exacerbates Mycobacterium tuberculosis induced human macrophage death.
Publication TypeJournal Article
Year of Publication2024
AuthorsLee AM, Nathan CF
JournalEMBO Rep
Volume25
Issue7
Pagination3064-3089
Date Published2024 Jul
ISSN1469-3178
KeywordsAnimals, Cell Death, Cells, Cultured, Humans, Interferon Type I, Macrophages, Mice, Mycobacterium tuberculosis, Signal Transduction, Tuberculosis
Abstract

Type I interferons (IFN-I) are implicated in exacerbation of tuberculosis (TB), but the mechanisms are unclear. Mouse macrophages infected with Mycobacterium tuberculosis (Mtb) produce IFN-I, which contributes to their death. Here we investigate whether the same is true for human monocyte-derived macrophages (MDM). MDM prepared by a conventional method markedly upregulate interferon-stimulated genes (ISGs) upon Mtb infection, while MDM prepared to better restrict Mtb do so much less. A mixture of antibodies inhibiting IFN-I signaling prevents ISG induction. Surprisingly, secreted IFN-I are undetectable until nearly two days after ISG induction. These same antibodies do not diminish Mtb-infected MDM death. MDM induce ISGs in response to picogram/mL levels of exogenous IFN-I while depleting similar quantities from the medium. Exogenous IFN-I increase the proportion of dead MDM. We speculate that Mtb-infected MDM produce and respond to minute levels of IFN-I, and that only some of the resultant signaling is susceptible to neutralizing antibodies. Many types of cells may secrete IFN-I in patients with TB, where IFN-I is likely to promote the death of infected macrophages.

DOI10.1038/s44319-024-00171-0
Alternate JournalEMBO Rep
PubMed ID38866980
PubMed Central IDPMC11239827
Grant ListR01 AI138940 / AI / NIAID NIH HHS / United States
RO1 AI138940 / / HHS | National Institutes of Health (NIH) /

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587